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Several studies have shown that positive surgical margins
(SM) are associated with BCR and need for salvage
treatments. Retrospective analysis of 377 consecutive open RPperformed between 2009 and 2016, with localized PCa.
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Our study showed no prognostic advantage of adjuvant RT compared with salvage RT in patients with positive SM.
Although there appears to be a trend towards a higher rate of BCR, a shorter time from surgery to the development of
BCR and a higher rate of hormone therapy, the presence of positive SM does not appear to have a significant impact on
disease progression and survival in patients with organ confined PCa.
The aim of our study was to evaluate the impact of
positive (SM) in patients with localized PCa who
underwent radical prostatectomy (RP), evaluating BCR,
survival and need for additional treatments.
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• Mean age: 63.0 ± 6.8 years















• Thirteen (21.3%) patients with positive margins performed adjuvant radiotherapy (RT). Overall survival of patients with positive
SM was 100% in those who did adjuvant RT and 95.8% in those who did not perform adjuvant RT.
• However, the cause of death in the two deceased patients was not related to PCa.
• No patient has been proposed for therapy with abiraterone, enzalutamide or docetaxel.
• Two (3.3%) patients with positive SM developed lymph nodes metastasis and one (1.6%) developed bone metastasis.
